Full-Time

Head of Market Access

Reimbursement and Policy, Kidney Care

Confirmed live in the last 24 hours

Baxter International

Baxter International

10,001+ employees

Provides essential medical products and services

Biotechnology
Healthcare

Senior, Expert

Newbury, UK

Position based in Newbury, Berkshire, with responsibilities across the UK/I and Nordics.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Proven experience of market access across UK/I and Nordics
  • Experience of at least 2 out of the following: Health Economics and Outcomes Research, Health Technology Assessment, Market Access, Real World Evidence
  • Minimum of 10 years in space of Health Economics and Market Access
  • Advanced degree (MS, MPH, PhD) in health economics, HTA and or Statistics
Responsibilities
  • Lead HEMAR Strategy (including policy, reimbursement and HTA) for the Vantive portfolio across the UK/I and Nordics
  • Execute strategies in focus geographies in collaboration with regional teams
  • Responsibility for economic evidence generation and dissemination to payers and providers including building capability across the commercial (evidence-based selling) and Medical Affairs organization
  • Provide geography specific intelligence working as a strategic partner for New Product Development (R&D) value proposition: Non-clinical stakeholder dimension, value-based pricing, target product profile (TPP)

Baxter International provides a wide range of medical products and services essential for healthcare. The company operates in several areas, including critical care, hospital care, nutritional care, renal care, and surgical care. Its products are used in various settings, from emergency rooms to home healthcare, helping to meet the needs of patients and healthcare professionals. Baxter develops, manufactures, and distributes medical devices, pharmaceuticals, and biotechnology products, generating revenue through sales to healthcare providers and institutions. A key aspect that sets Baxter apart from competitors is its recent acquisition of Hillrom, which enhances its ability to offer comprehensive healthcare solutions. The company's goal is to improve care outcomes and increase access to healthcare through continuous innovation and a focus on patient needs.

Company Stage

IPO

Total Funding

N/A

Headquarters

Deerfield, Illinois

Founded

1931

Simplify Jobs

Simplify's Take

What believers are saying

  • Needle-free injection technology aligns with Baxter's patient-centric innovation strategy.
  • Home healthcare solutions expansion supports decentralized patient care, benefiting Baxter.
  • Behavioral science in healthcare improves patient adherence, enhancing Baxter's renal care solutions.

What critics are saying

  • Needle-free technology may disrupt Baxter's traditional self-administered therapies market.
  • Home healthcare investment may reduce demand for Baxter's hospital care segment.
  • Digital health trend requires Baxter to continuously innovate to remain competitive.

What makes Baxter International unique

  • Baxter's acquisition of Hillrom enhances its comprehensive healthcare solutions portfolio.
  • Partnership with Ayogo Health strengthens Baxter's digital health capabilities for kidney disease.
  • Baxter's investment in Medically Home supports leadership in hospital-level care at home.

Help us improve and share your feedback! Did you find this helpful?